Literature DB >> 12783964

Bone marrow immunohistology of plasma cell neoplasms.

A Wei1, S Juneja.   

Abstract

The application of immunohistology to the spectrum of plasma cell disorders has yet to be incorporated widely into routine haematology practice. This technique enables the direct visualisation of specific surface and cytoplasmic antigens in the context of the individual cell and the surrounding anatomical neighbourhood. This review outlines the role of bone marrow immunohistology in the laboratory evaluation of patients with suspected and established plasma cell neoplasms and its emerging role in understanding myeloma biology for possible future therapeutic application.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12783964      PMCID： PMC1769975          DOI： 10.1136/jcp.56.6.406

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  55 in total

1.  Marked plasmacytosis and immunoglobulin abnormalities following infusion of streptokinase.

Authors:  L Gorden; C Smith; S E Graber
Journal:  Am J Med Sci       Date:  1991-03       Impact factor: 2.378

2.  The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis.

Authors:  S S Wu; K Brady; J J Anderson; R Vezina; M Skinner; R S Neiman; B C Wolf
Journal:  Am J Clin Pathol       Date:  1991-07       Impact factor: 2.493

3.  The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myeloma.

Authors:  L M Rimsza; K Campbell; W S Dalton; S Salmon; G Willcox; T M Grogan
Journal:  Leuk Lymphoma       Date:  1999-07

4.  Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.

Authors:  Andy C Rawstron; Faith E Davies; Ranjit DasGupta; A John Ashcroft; Russell Patmore; Mark T Drayson; Roger G Owen; Andrew S Jack; J Anthony Child; Gareth J Morgan
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.

Authors:  J F San Miguel; M González; A Gascón; M J Moro; J M Hernández; F Ortega; R Jimenez; L Guerras; M Romero; F Casanova
Journal:  Br J Haematol       Date:  1991-02       Impact factor: 6.998

6.  Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature.

Authors:  Annette Lebeau; Evelyn Zeindl-Eberhart; Eva-Christina Müller; Josef Müller-Höcker; Peter Roman Jungblut; Bertold Emmerich; Udo Löhrs
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition.

Authors:  R Bartl; B Frisch; G Mahl; R Burkhardt; A Fateh-Moghadam; R Pappenberger; W Sommerfeld; G Hoffmann-Fezer
Journal:  Scand J Haematol       Date:  1983-10

8.  Histology and immunohistology of bone marrow biopsy in multiple myeloma.

Authors:  S Pileri; S Poggi; P Baglioni; M Montanari; E Sabattini; P Galieni; P L Tazzari; M Gobbi; M Cavo; B Falini
Journal:  Eur J Haematol Suppl       Date:  1989

9.  Bone-marrow plasmocytosis--an immunohistological study.

Authors:  F Eckert; L Schmid; D Kradolfer; U Schmid
Journal:  Blut       Date:  1986-07

10.  Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma.

Authors:  Naohi Sahara; Akihiro Takeshita; Kazuyuki Shigeno; Shinya Fujisawa; Kaori Takeshita; Kensuke Naito; Michio Ihara; Takaaki Ono; Sadahiro Tamashima; Kenji Nara; Kazunori Ohnishi; Ryuzo Ohno
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998
View more
  10 in total

1.  Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis.

Authors:  Joo Hee Lee; Ga Yeon Lee; Seok Jin Kim; Ki Hyun Kim; Eun-Seok Jeon; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2015-05-13

2.  Variant morphology in multiple myeloma.

Authors:  Prasad R Koduri; Swarnalata Gowrishankar; Vijay Kumar Malladi
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

3.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

4.  Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Authors:  Maria G Ioannou; Efstathios Stathakis; Andreas C Lazaris; Thomas Papathomas; Evangelos Tsiambas; George K Koukoulis
Journal:  Pathol Oncol Res       Date:  2008-06-14       Impact factor: 3.201

Review 5.  Reticuloendothelial malignancy of head and neck: A comprehensive review.

Authors:  L Malathi; R Amsaveni; N Anitha; N Balachander
Journal:  J Pharm Bioallied Sci       Date:  2015-04

6.  Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.

Authors:  Teresa Paíno; María E Sarasquete; Bruno Paiva; Patryk Krzeminski; Laura San-Segundo; Luis A Corchete; Alba Redondo; Mercedes Garayoa; Ramón García-Sanz; Norma C Gutiérrez; Enrique M Ocio; Jesús F San-Miguel
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits.

Authors:  Piotr Kozlowski; Scott Montgomery; Rahel Befekadu; Victoria Hahn-Strömberg
Journal:  J Blood Med       Date:  2017-03-06

8.  Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis.

Authors:  Joseph Tadros; Stacey Goodman; Eric R Tkaczyk
Journal:  Dermatol Pract Concept       Date:  2018-07-31

9.  Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study.

Authors:  Jasmita Dass; Sudheer Arava; Pravas Chandra Mishra; Amit Kumar Dinda; Hara Prasad Pati
Journal:  South Asian J Cancer       Date:  2019 Jan-Mar

10.  Solitary Bone Plasmacytoma of the Pelvis: A Rare Tumor.

Authors:  Samir Karmali; André Barros; Barbara Rosa; Pedro Campos; Ricardo Gonçalves; Daniel Sá da Costa; Dolores López-Presa
Journal:  Rare Tumors       Date:  2016-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.